ALAD Antikörper (C-Term)
Kurzübersicht für ALAD Antikörper (C-Term) (ABIN452730)
Target
Alle ALAD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- This antibody detects ALAD at C-term.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human ALAD
-
-
-
-
Applikationshinweise
-
Western blot: 1: 50 - 1: 100. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.121 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
-
-
- ALAD (Aminolevulinate Dehydratase (ALAD))
-
Andere Bezeichnung
- ALAD
-
Hintergrund
- The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 Molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway, zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria.Synonyms: ALADH, Delta-aminolevulinic acid dehydratase, Porphobilinogen synthase
-
Molekulargewicht
- 36295 Da
-
Gen-ID
- 210
-
NCBI Accession
- NP_000022
-
UniProt
- P13716
Target
-